The prognostic impact of subclonal IDH1 mutation in grade 2-4 astrocytomas.
Vij M, Yokoda RT, Rashidipour O, Tran I, Vasudevaraja V, Snuderl M, Yong RL, Cobb WS, Umphlett M, Walker JM, Tsankova NM, Richardson TE.
Vij M, et al. Among authors: tsankova nm.
Neurooncol Adv. 2023 May 29;5(1):vdad069. doi: 10.1093/noajnl/vdad069. eCollection 2023 Jan-Dec.
Neurooncol Adv. 2023.
PMID: 37324217
Free PMC article.